170 related articles for article (PubMed ID: 21696692)
1. Letter: Penile Kaposi sarcoma: A case of complete resolution with highly active antiretroviral therapy alone.
Pinto-Almeida T; Torres T; Rosmaninho A; Sanches M; Alves R; Caetano M; Selores M
Dermatol Online J; 2011 Jun; 17(6):12. PubMed ID: 21696692
[TBL] [Abstract][Full Text] [Related]
2. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
Lasso M; Pérez J; Noriega L; Malebrán A; Espinoza S
Rev Med Chil; 2003 May; 131(5):483-90. PubMed ID: 12879808
[TBL] [Abstract][Full Text] [Related]
3. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral treatment initiation.
Chan DJ
Int J STD AIDS; 2006 Jan; 17(1):72. PubMed ID: 16409689
[No Abstract] [Full Text] [Related]
7. Response of AIDS-associated Kaposi sarcoma to highly active antiretroviral therapy alone.
Paparizos VA; Kyriakis KP; Papastamopoulos V; Hadjivassiliou M; Stavrianeas NG
J Acquir Immune Defic Syndr; 2002 Jun; 30(2):257-8. PubMed ID: 12045689
[No Abstract] [Full Text] [Related]
8. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
Noy A; Scadden DT; Lee J; Dezube BJ; Aboulafia D; Tulpule A; Walmsley S; Gill P
J Clin Oncol; 2005 Feb; 23(5):990-8. PubMed ID: 15598977
[TBL] [Abstract][Full Text] [Related]
9. Response to: a retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).
Maurer T; Leslie K; Unemori P
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):73. PubMed ID: 20484734
[No Abstract] [Full Text] [Related]
10. Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient.
Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Ahilasamy N
Int J STD AIDS; 2008 Nov; 19(11):786-8. PubMed ID: 18931277
[TBL] [Abstract][Full Text] [Related]
11. HIV-associated Kaposi's sarcoma.
Seybold U; Mayr D; Degenhart C; Bogner JR
Infection; 2008 Feb; 36(1):96-7. PubMed ID: 18231715
[No Abstract] [Full Text] [Related]
12. Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.
Nguyen HQ; Magaret AS; Kitahata MM; Van Rompaey SE; Wald A; Casper C
AIDS; 2008 May; 22(8):937-45. PubMed ID: 18453853
[TBL] [Abstract][Full Text] [Related]
13. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
14. HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load.
Maurer T; Ponte M; Leslie K
N Engl J Med; 2007 Sep; 357(13):1352-3. PubMed ID: 17898112
[No Abstract] [Full Text] [Related]
15. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy.
Connick E; Kane MA; White IE; Ryder J; Campbell TB
Clin Infect Dis; 2004 Dec; 39(12):1852-5. PubMed ID: 15578411
[TBL] [Abstract][Full Text] [Related]
16. Penile Kaposi's Sarcoma.
Grandi V; De Francesco I
N Engl J Med; 2020 Mar; 382(12):e20. PubMed ID: 32187472
[No Abstract] [Full Text] [Related]
17. AIDS-associated Kaposi's sarcoma associated with a low viral load and a high CD4 cell count.
Stebbing J; Powles T; Bower M
AIDS; 2008 Feb; 22(4):551-2. PubMed ID: 18301078
[No Abstract] [Full Text] [Related]
18. Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor.
Murdaca G; Campelli A; Setti M; Indiveri F; Puppo F
AIDS; 2002 Jan; 16(2):304-5. PubMed ID: 11807324
[No Abstract] [Full Text] [Related]
19. Immune reconstitution in several forms.
Ball SC
AIDS Read; 2005 Jan; 15(1):17-20. PubMed ID: 15685730
[No Abstract] [Full Text] [Related]
20. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
